Organogenesis Holdings (ORGO) Accounts Payables (2017 - 2026)

Organogenesis Holdings' Accounts Payables history runs 10 years deep, the most recent figure standing at $28.6 million for Q1 2026.

• On a quarterly basis, Accounts Payables rose 16.04% year-over-year to $28.6 million in Q1 2026; TTM through Mar 2026 was $28.6 million, a 16.04% increase from a year earlier, with the FY2025 full-year figure at $31.9 million, up 10.51% from the prior year.
• Accounts Payables fell to $28.6 million in Q1 2026 per ORGO's latest filing, from $31.9 million in the prior quarter.
• Across five years, Accounts Payables topped out at $40.2 million in Q3 2025 and bottomed at $23.2 million in Q1 2024.
• The 5-year median for Accounts Payables is $29.4 million (2024), against an average of $30.0 million.
• Across the five-year window, Accounts Payables dropped 29.43% in 2023 and soared 67.78% in 2025, its largest moves.
• Year by year, Accounts Payables stood at $32.3 million in 2022, then decreased by 4.97% to $30.7 million in 2023, then slipped by 5.9% to $28.9 million in 2024, then grew by 10.51% to $31.9 million in 2025, then declined by 10.44% to $28.6 million in 2026.
• Per Business Quant, the three latest ORGO Accounts Payables figures stand at $28.6 million (Q1 2026), $31.9 million (Q4 2025), and $40.2 million (Q3 2025).